Form 4 for BSX Boston Scientific
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-15 · accession 0001225208-23-002148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $47.29 | -1,219 | 283.9K | -0.4% | -$57.6K |
| D | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $47.14 | -7,572 | 276.3K | -3% | -$356.9K |
| DM | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $4.77 | +11.7K | 285.1K | +4% | +$56.0K |
| DM | 2023-02-16 | 2023-02-15 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | -11.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | F | D | 1,219 | $47.29 | 283,888 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-15 | S | D | 7,572 | $47.14 | 276,316 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.993 to $47.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-02-15 | M | A | 7,572 | $7.39 | 280,954 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-15 | M | A | 4,153 | $0.00 | 285,107 | D | — | — | (F2) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 5 | Derivative | Deferred Stock Units | 2023-02-15 | M | D | 4,153 | $0.00 | 0 | D | — · — to 2023-02-15 | 4,153 Common Stock | (F2) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F4) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-02-15 | M | D | 7,572 | $0.00 | 0 | D | $7.39 · — to 2023-02-28 | 7,572 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant. |